Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.5990
0.00 (0.00%)
At close: Apr 15, 2026
Orgenesis Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1.04 | 0.53 | 36.03 | 35.5 | 7.65 | |
Revenue Growth (YoY) | 95.28% | -98.53% | 1.47% | 363.96% | 96.25% |
Cost of Revenue | 1.93 | 6.26 | 5.13 | - | - |
Gross Profit | -0.89 | -5.73 | 30.89 | 35.5 | 7.65 |
Selling, General & Admin | 14.77 | 35.13 | 15.59 | 14.71 | 18.29 |
Research & Development | 9.62 | 10.62 | 21.93 | 36.64 | 83.99 |
Amortization of Goodwill & Intangibles | 0.73 | 0.72 | 0.91 | 0.95 | 0.48 |
Operating Expenses | 25.12 | 46.48 | 38.43 | 52.3 | 102.76 |
Operating Income | -26.02 | -52.2 | -7.54 | -16.8 | -95.1 |
Interest Expense | -3.74 | -2.17 | -1.82 | -0.94 | -1.25 |
Earnings From Equity Investments | -0.01 | -0.73 | -1.51 | -0.27 | 0.11 |
Currency Exchange Gain (Loss) | -0.78 | -0.33 | -0.15 | -0.57 | -0.16 |
Other Non Operating Income (Expenses) | -4.29 | -0 | 0.17 | 2.5 | 0.36 |
EBT Excluding Unusual Items | -34.84 | -55.43 | -10.85 | -16.09 | -96.05 |
Merger & Restructuring Charges | -0.05 | - | - | - | -0.68 |
Impairment of Goodwill | -1.21 | - | - | - | - |
Gain (Loss) on Sale of Investments | - | -0.7 | - | - | - |
Gain (Loss) on Sale of Assets | 5.09 | -5.34 | - | - | - |
Asset Writedown | -17.13 | - | -1.06 | - | - |
Other Unusual Items | -0.78 | -2.97 | -0.05 | -1.87 | - |
Pretax Income | -48.92 | -64.45 | -11.96 | -17.95 | -96.74 |
Income Tax Expense | 0.1 | 0.47 | 0.21 | 0.11 | -1.61 |
Earnings From Continuing Operations | -49.01 | -64.92 | -12.17 | -18.06 | -95.13 |
Earnings From Discontinued Operations | - | - | - | - | 96.2 |
Net Income to Company | -49.01 | -64.92 | -12.17 | -18.06 | 1.07 |
Minority Interest in Earnings | 0.85 | 9.56 | -2.72 | 0.01 | 0.04 |
Net Income | -48.17 | -55.36 | -14.89 | -18.05 | 1.11 |
Preferred Dividends & Other Adjustments | - | - | - | - | -5.16 |
Net Income to Common | -48.17 | -55.36 | -14.89 | -18.05 | 6.27 |
Shares Outstanding (Basic) | 4 | 3 | 3 | 2 | 2 |
Shares Outstanding (Diluted) | 4 | 3 | 3 | 2 | 2 |
Shares Change (YoY) | 45.16% | 15.59% | 3.39% | 13.85% | 34.02% |
EPS (Basic) | -11.44 | -19.08 | -5.93 | -7.44 | 2.94 |
EPS (Diluted) | -11.44 | -19.08 | -5.93 | -7.44 | 2.94 |
Free Cash Flow | -17.34 | -16.93 | -37.34 | -34.73 | -79.57 |
Free Cash Flow Per Share | -4.12 | -5.84 | -14.88 | -14.31 | -37.32 |
Gross Margin | -86.28% | - | 85.75% | 100.00% | 100.00% |
Operating Margin | -2513.53% | -9849.62% | -20.93% | -47.32% | -1242.85% |
Profit Margin | -4653.62% | -10445.47% | -41.33% | -50.85% | 81.94% |
Free Cash Flow Margin | -1675.27% | -3194.91% | -103.65% | -97.83% | -1039.87% |
EBITDA | -23.93 | -50.64 | -5.56 | -15.58 | -94.56 |
EBITDA Margin | - | - | -15.44% | -43.88% | - |
D&A For EBITDA | 2.09 | 1.56 | 1.98 | 1.22 | 0.54 |
EBIT | -26.02 | -52.2 | -7.54 | -16.8 | -95.1 |
EBIT Margin | - | - | -20.93% | -47.32% | - |
Revenue as Reported | - | - | 36.03 | 35.5 | 7.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.